Ruiz-de-León Gonzalo, Cortés-Eslava Daniela, Hernández-Pacheco Esther, Serrera-Figallo María-Ángeles, Torres-Lagares Daniel, Baus-Domínguez María
Department of Stomatology, Faculty of Dentistry, University of Seville, C/Avicena S/N, 41009 Seville, Spain.
Gels. 2025 Jun 13;11(6):455. doi: 10.3390/gels11060455.
Biopolymer-based dermal fillers have gained attention in facial aesthetics due to their biocompatibility, gel-forming properties, and capacity to stimulate tissue regeneration. However, evidence regarding their clinical performance remains scattered and inconsistent. This systematic review evaluates the current scientific literature on the effectiveness and safety of injectable biopolymers used in facial aesthetic procedures. A systematic search was conducted in PubMed, MEDLINE, and Embase databases for studies published between 2016 and 2024. Only human studies in English assessing clinical efficacy, safety, adverse events, and patient satisfaction were included. Of the 280 articles initially identified, 9 met the inclusion criteria. The selected studies showed improvements in facial volume and wrinkle reduction with gel-based biopolymers such as poly-L-lactic acid (PLLA), polycaprolactone (PCL), and polymethylmethacrylate (PMMA). Most studies reported high patient satisfaction and a low incidence of serious adverse effects. However, methodological heterogeneity and limited long-term data reduced the strength of the evidence. While injectable biopolymers appear to be effective and generally safe, current evidence is limited and variable. Further multicenter randomized trials with standardized protocols and longer follow-up periods are needed. Clinicians should apply these materials with caution, ensuring individualized treatment planning and careful risk assessment.
基于生物聚合物的真皮填充剂因其生物相容性、凝胶形成特性以及刺激组织再生的能力而在面部美学领域受到关注。然而,关于其临床性能的证据仍然分散且不一致。本系统评价评估了目前关于面部美容手术中使用的可注射生物聚合物的有效性和安全性的科学文献。在PubMed、MEDLINE和Embase数据库中进行了系统检索,以查找2016年至2024年发表的研究。仅纳入了以英文发表的评估临床疗效、安全性、不良事件和患者满意度的人体研究。在最初识别的280篇文章中,有9篇符合纳入标准。所选研究表明,使用基于凝胶的生物聚合物,如聚-L-乳酸(PLLA)、聚己内酯(PCL)和聚甲基丙烯酸甲酯(PMMA),面部容积增加且皱纹减少。大多数研究报告患者满意度高,严重不良反应发生率低。然而,方法学的异质性和有限的长期数据降低了证据的强度。虽然可注射生物聚合物似乎有效且总体安全,但目前的证据有限且存在差异。需要进一步开展多中心随机试验,采用标准化方案并延长随访期。临床医生应谨慎应用这些材料,确保个体化治疗方案制定和仔细的风险评估。